UroGen CFO’s Insider Buying Signals a Strategic Upswing in Uro‑Oncology
UroGen Pharma’s CFO buys shares amid a slump, signaling confidence in its uro‑oncology pipeline and potential rebound. Discover what insider trades mean for investors.
4 minutes to read